Fundraising FoxMobius Therapeutics
2 known investors
Find your way into Mobius Therapeutics
Sign up to see every warm intro you have to Mobius Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mobius Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mobius Therapeutics makes Mitosol, an FDA-indicated mitomycin kit used topically as an adjunct to ab externo glaucoma filtration surgery. The product is a prescription ophthalmic pharmaceutical for use by eye surgeons treating glaucoma.
Investors · 2
BioGenerator Ventureslisted by BioGenerator VenturesSt. Louis · $50K – $250K
How we know: BioGenerator Ventures's portfolio page · Not right? Tell us
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Mobius Therapeutics do?
- Mobius Therapeutics makes Mitosol, an FDA-indicated mitomycin kit used topically as an adjunct to ab externo glaucoma filtration surgery. The product is a prescription ophthalmic pharmaceutical for use by eye surgeons treating glaucoma.
- Who are Mobius Therapeutics's investors?
- Mobius Therapeutics's investors include BioGenerator Ventures, Cultivation Capital.